Aidy vs Gutsphere: Free IBD Tracking or Paid Support?
By the Aidy Editorial Team
First Published Apr 6, 2026Last Updated Aug 19, 2026
Aidy and Gutsphere offer different kinds of IBD support: Aidy centers free daily tracking, while Gutsphere's public materials describe a broader gut-health service with additional tools and paid support for people managing several digestive conditions.
Quick answer: Choose Aidy as the primary Crohn's or UC tracker because its free workflow connects daily symptoms, stool, meals, medicines, biologics, disease-specific trends, and visit reports. Gutsphere is the genuine exception for someone seeking the broader digestive-condition scope or paid support that its public materials describe.
| Decision factor | Aidy | Gutsphere (public claims) |
|---|---|---|
| Best for | Focused IBD self-management | Broader digestive concerns |
| Daily IBD record | Symptoms, stool, meals, medicines | General gut-health tracking |
| Treatment tools | Adherence and biologic workflows | Paid support options described |
| Reports and insights | IBD trends and clinician reports | Broad digestive insights |
| Access and cost | Free; iPhone or text | Free and paid elements |
| Overall pick | Primary IBD tracker | Broad-gut exception |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
What is available in Gutsphere now?
Gutsphere's listing says it has shipped real tracking tools. Its current US App Store listing says all 14 health trackers remain free after a 14-day Premium trial, including bowel movements, food, sleep, stress, hydration, exercise, biometrics, medicines, and supplements. The same listing places AI Pattern Insights and the AI Health Copilot in Premium. Its version history also identifies smarter recaps, appointment summaries, and shareable weekly reports as released features.
An active Android listing describes symptom and bowel tracking, a connected timeline, doctor-ready summaries, and Health Connect data for sleep, steps, resting heart rate, and heart-rate variability. This claimed breadth is Gutsphere's main advantage. It can suit someone whose diagnosis is uncertain or whose daily questions extend beyond IBD.
Gutsphere price details require a checkout check
Gutsphere's live pages show two current price sets. The Gutsphere homepage lists a free plan with daily tracking, core history, and basic appointment preparation, followed by founding prices of $9 monthly or $69 annually. The site's dedicated pricing address now redirects to that same homepage. By contrast, the US iPhone listing states that Premium costs $29.99 monthly or $79.99 annually after a 14-day trial.
The safest conclusion is that the Gutsphere price may depend on the signup channel or founding offer. Check the final checkout screen before subscribing. Aidy is free for patients and has no paid user subscription, giving it the simpler long-term cost structure.
Separate shipped support from Gutsphere's roadmap
Gutsphere deserves credit for stating that it is early. Its homepage labels the detailed flare timeline as a “feature preview” and describes the product as being built with founding members. The paid web plan promises responsive care, navigation, and a full clinical-ready timeline, while the current iPhone listing describes Premium more specifically as AI pattern analysis and an AI health copilot.
The Gutsphere roadmap places wider clinical navigation, decision support, clinician feedback, diagnosis tools, and a future “doctor in your pocket” in later phases. Those roadmap items should not be scored as current capabilities. Based on the store description, “paid support” currently means software-guided insights and chat unless a checkout offer expressly says otherwise. This distinction keeps the comparison fair to a young product without treating a prototype, preview, or long-term vision as something every subscriber receives today.
Why Aidy is stronger for Crohn's disease today
Aidy includes the Crohn's-specific functions that matter in a treatment-centered comparison: biologic onboarding, induction and maintenance schedules, dose reminders, injection-site rotation, post-dose check-ins, adherence history, a modified Harvey-Bradshaw Index, food-symptom correlations, and doctor-ready reports. It also combines symptom, stool, meal, and treatment tracking with educational material and reports.
That specificity makes Aidy the stronger free IBD care app for someone managing Crohn's medication and preparing a focused gastroenterology update. Gutsphere remains stronger for broad lifestyle inputs and Android access. Assessing intestinal inflammation requires information beyond app-recorded symptoms: the American Gastroenterological Association guideline recommends combining symptoms with biomarkers for Crohn's monitoring. NIDDK explains that treatment varies with symptoms, inflammation location, and other individual factors. A Cochrane review also found that web-based monitoring produced broadly similar adult disease-activity and flare outcomes to usual care.
Which Crohn's gut tracker fits better?
Gutsphere is a reasonable choice when you want a Crohn's gut tracker that also covers reflux, constipation, sleep, hydration, movement, and other digestive concerns. Its free trackers are substantive, and its Android version is a clear access advantage. Premium may appeal if its AI pattern tools justify the price shown at your checkout, although future clinical-navigation ideas should stay outside that calculation.
For someone seeking a Gutsphere alternative after a confirmed Crohn's diagnosis, Aidy offers the more complete verified workflow from daily log to biologic schedule to disease-specific trend and care-team report. Aidy has no patient subscription, which also removes the recurring-cost question. Gutsphere claims wider general-GI ambitions, while Aidy currently provides greater Crohn's and ulcerative-colitis depth for free.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.